Nuzenio

Samsung Epis

Samsung Epis news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

company 8 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Samsung Bioepis lines up Opuviz syringe as European aflibercept rivals multiply - The Pharma LetterThe Pharma Letter · Mon, 10 Aug 2026 12:41:14 GMTSamsung Bioepis Files South Korea's First Approval for Biosimilar of Merck's $32.4 Billion Cancer Drug Keytruda - finance.biggo.comfinance.biggo.com · Mon, 10 Aug 2026 09:15:00 GMTSamsung Epis Holdings Co Applies To Korea Food Ministry For Approval Of Pembrolizumab Biosimilar - TradingViewTradingView · Mon, 10 Aug 2026 08:05:57 GMTSamsung Bioepis files first Korea application for Keytruda biosimilar - CHOSUNBIZ - ChosunbizChosunbiz · Mon, 10 Aug 2026 07:36:00 GMTSamsung Bioepis battles Janssen, Pfizer, Novartis in global biosimilar suits - CHOSUNBIZ - ChosunbizChosunbiz · Mon, 10 Aug 2026 00:42:00 GMTSamsung Bioepis battles Janssen, Pfizer, Novartis in global biosimilar fights - CHOSUNBIZ - ChosunbizChosunbiz · Mon, 10 Aug 2026 00:42:00 GMTTopic: Samsung Epis - The Korea TimesThe Korea Times · Mon, 03 Aug 2026 14:05:19 GMTPrice to book forward of Samsung Epis Holdings Co., Ltd. – KRX:0126Z0 - TradingViewTradingView · Sat, 01 Aug 2026 15:25:00 GMT

Timeline

Mon, 10 Aug 2026 12:41:14 GMTSamsung Bioepis lines up Opuviz syringe as European aflibercept rivals multiply - The Pharma Letter
Mon, 10 Aug 2026 09:15:00 GMTSamsung Bioepis Files South Korea's First Approval for Biosimilar of Merck's $32.4 Billion Cancer Drug Keytruda - finance.biggo.com
Mon, 10 Aug 2026 08:05:57 GMTSamsung Epis Holdings Co Applies To Korea Food Ministry For Approval Of Pembrolizumab Biosimilar - TradingView
Mon, 10 Aug 2026 07:36:00 GMTSamsung Bioepis files first Korea application for Keytruda biosimilar - CHOSUNBIZ - Chosunbiz
Mon, 10 Aug 2026 00:42:00 GMTSamsung Bioepis battles Janssen, Pfizer, Novartis in global biosimilar suits - CHOSUNBIZ - Chosunbiz
Mon, 10 Aug 2026 00:42:00 GMTSamsung Bioepis battles Janssen, Pfizer, Novartis in global biosimilar fights - CHOSUNBIZ - Chosunbiz

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Samsung Epis.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.